Virginia Kaklamani, MD, DSc, provides an overview of the goals of care for HER2+ breast cancer.
Treatment Options for Early-Stage HER2-Positive Breast Cancer
A review of the currently available frontline treatment options for HER2+ breast cancer.
Virginia Kaklamani, MD, DSc, provides an overview of the goals of care for HER2+ breast cancer.
Dr. Virginia Kaklamani discusses the role of maintenance therapies for HER2+ breast cancer.
Advice for community physicians treating HER2+ breast cancer.
Advertisement
Advertisement
Trending on CancerNetwork
1
Cancer Vaccine/Pembrolizumab Improves PFS in Treatment-Naive Melanoma
2
Relacorilant Regimen Improves PFS in Platinum-Resistant Ovarian Cancer
3
AI Partnership May Optimize Standardized Oncologic Radiotherapy Delivery
4
Sacituzumab Tirumotecan Improves Survival in Second-Line EGFR+ NSCLC
5
